Valeant Names Anne C. Whitaker to New Executive VP and Group Chairman Position
Friday, May 8 2015 | 00 h 00 min | Appointments
Quebec-based Valeant Pharmaceuticals, Inc., announced that Anne C. Whitaker, formerly of Synta, Sanofi and GlaxoSmithKline, will join Valeant in a newly created position of executive vice president and company group chairman.
Whitaker was recognized for her efforts in prioritizing and streamlining pharmaceutical new product pipeline opportunities.
“Anne is an accomplished pharmaceutical executive with more than 24 years of experience in key leadership roles across health care sales… She also has a proven track record of success in delivering sustainable growth and profitability,” said J. Michael Pearson, Valeant’s chairman and CEO.
The company also announced that Howard B. Schiller, Chief Financial Officer, has advised the Company of his decision to step down once a successor is appointed. Mr. Schiller will remain in his current position as the search for his replacement proceeds.
